Evaluation and Critical Appraisal of a Random Sample of Drug Information Practice In United States Academic and Industry

  • PDF / 598,569 Bytes
  • 6 Pages / 504 x 719.759 pts Page_size
  • 11 Downloads / 164 Views

DOWNLOAD

REPORT


0092-8615/2000 Copyright 0 ZOO0 Drug Information Association Inc.

EVALUATION AND CRITICAL APPRAISAL OF A RANDOM SAMPLE OF DRUG INFORMATION PRACTICE IN UNITED STATES ACADEMIC AND INDUSTRY MEDICAL INFORMATION CENTERS MEGHANE. SHANNON, PHARMD Drug Information Resident, Searle, Skokie, Illinois, and University of Illinois at Chicago, Chicago, Illinois

SUSANE. MALECHA,PHARMD Director, Cardiovascular Applied Therapeutics, Global Healthcare Resources, Searle, Skokie, Illinois

AMYJ. CHA,FHARMD Assistant Director, New Product Development, Global Healthcare Resources, Searle, Skolue, Illinois

MARYLYNNMOODY,BSPHARM Director, Drug Information Center, University of Illinois at Chicago, Chicago, Illinois

Capturing the best practices in an academic and pharmaceutical industry drug information center, and in turn, incorporating them into improved methodical work procedures and current services, is a goal for most drug information centers. The best practices should represent the most efficient and productive means of providing drug information. Knowing this information helps to improve workflow, decrease costs, increase overall productivity and projiciency, and improve employee and customer satisfaction. In order to critically evaluate the current situation and fully comprehend the established practice standards, an evaluation survey was conducted. Two separate surveys were sent electronically or fared to both academic and industry drug information departments. The survey focused on utilization of the drug information center within the department, practice procedures and resources utilized in answering drug information requests, training and evaluation of employees, means of providing quality assurance, and technical and operational logistics. A description and results of this survey are described. Key Words: Drug information; Academia; Pharmaceutical industry; Survey

INTRODUCTION THE GOAL OF A DRUG information center is to have the most efficient system in place

Presented in poster form at the DIA “Medical Communications Meeting.” Residents Poster Session, March 13. 2000. Washington, District of Columbia. Reprint address: Meghan E. Shannon, PharmD, 10 Cross St.. Madison, NJ 07940.

when providing service. An efficient system improves productivity and proficiency, improves workflow, employee, and customer satisfaction; decreases costs; and affords the ability to provide the best overall product. To characterize the means of obtaining this proficiency and productivity within drug information, a survey was done to access the current practice standards. The survey also captured information on different responsi-

1133

Downloaded from dij.sagepub.com at NORTHERN ARIZONA UNIVERSITY on May 25, 2015

M . E. Shannon, S. E. Malecha, A. J. Cha, and M . L. Moody

1134

bilities of various centers, means of providing quality assurance, the training and evaluation of employees, and, finally, the similarities and differences between academic-based and pharmaceutical industry drug information departments. By evaluating the procedures of